11 Results for "

WS cells

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "WS cells" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-139109
CAS No.: 115970-66-6
Purity:  99.87%
Synonyms: ADS 780WS
IR-783 (ADS 780WS) is a heptamethine cyanine dye. IR-783 induces Mitochondrial membrane potential loss, ATP depletion, mitochondrial permeability transition pore opening, Cytochrome c release and Apoptosis in breast cancer cells. IR-783 promotes the translocation of Drp1 from the cytosol to mitochondria. IR-783 increases the expression of mitochondrial fission proteins such as MFF and Fission-1. IR-783 possesses imaging, cancer-targeting and anticancer properties. IR-783 exerts anticancer effects against breast cancer. IR-783 can be used in breast cancer-related research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-168528
CAS No.: 3112403-98-9
Target:  

P-glycoprotein

Research Areas:  

Cancer

WS-917 is a potent and orally active ABCB1 modulator. WS-917 enhances ABCB1 ATPase activity. WS-917 significantly enhances the antitumor effect of paclitaxel combined with anti-PD-1 antibody. WS-917 promotes CD8 + T-cell activation .
loading...
    loading...
Cat. No.: HY-12461
CAS No.: 1421227-53-3
Purity:  99.94%
WS6 is an IkB kinase and EBP1 inhibitor, with IC50 values of 0.24 nM, 0.21 nM, and 40.48 nM in MV4-11, MOLM13, and K562 cells, respectively. WS6 promotes the proliferation of alpha and beta cells in the pancreas, has antioxidant and anti-inflammatory activities, and can alleviate depression like behavior in rats [1][2][4].
loading...
    loading...
Cat. No.: HY-12462
CAS No.: 1421227-52-2
Purity:  98.00%
WS3 is an allosteric inhibitor of 14-3-3 (14-3-3ζ: Kd = 2.29 μM). WS3 activates GSK3β by disrupting the binding of 14-3-3-pGSK3β, promotes the ubiquitination and degradation of NRF2, and inhibits the NRF2-ARE signaling pathway (IC50 = 135 nM). It exerts antioxidant inhibition and chemotherapeutic/ferroptosis sensitizing effects in tumors with hyperactivated NRF2. WS3 binds to EBP1/IKKε and promotes the proliferation of β cells and retinal pigment epithelial (RPE) cells, which can be applied to islet regeneration and RPE expansion transplantation . WS3 is applicable to research related to age-related macular degeneration, retinal degeneration and non-small cell lung cancer .
loading...
    loading...
Cat. No.: HY-111781
CAS No.: 2155853-43-1
Synonyms: WS-413
Target:  

Btk

Research Areas:  

Cancer

Civorebrutinib (WS-413) is a selective, orally active BTK and TEC inhibitor with an IC50 of <100 nM for both targets. Civorebrutinib inhibits B cell activation. Civorebrutinib significantly suppresses the in vivo growth of diffuse large B-cell lymphoma cells. Civorebrutinib can be used for the research of diffuse large B-cell lymphoma .
loading...
    loading...
Cat. No.: HY-139848
CAS No.: 2891562-77-7
Purity:  98.14%
Target:  

P-glycoprotein

Research Areas:  

Cancer

WS-898 is a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC50 = 5.0, 3.67, and 3.68 nM, respectively).
loading...
    loading...
Cat. No.: HY-118612
CAS No.: 249937-52-8
Purity:  99.77%
Target:  

p38 MAPK

Research Areas:  

Others

RO3201195 (compound 1) is an inhibitor of p38 MAPK. RO3201195 inhibits WS cell proliferation with IC50 value of 190 nM .
loading...
    loading...
Cat. No.: HY-178716
CAS No.: 3093350-55-8
Target:  

Phosphatase IFNAR STAT JAK

Research Areas:  

Cancer

PTPN2/1-IN-4 (Compound WS35) is an orally active, dual-functional inhibitor of PTPN1 and PTPN2 with IC50s of 12.8 and 5.8 nM for PTPN1 and PTPN2, respectively. PTPN2/1-IN-4 modulates the IFNγ-JAK-STAT signaling pathway and significantly augments CD8+ T-cell tumor infiltration. PTPN2/1-IN-4 has potent anticancer activity, robustly inhibiting tumor growth both as a monotherapy and in combination with an anti-PD-1 antibody in B16-OVA syngeneic mouse models .
loading...
    loading...
Cat. No.: HY-161470
CAS No.: 2247544-03-0
WS-384 is a dual LSD1 and DCN1-UBC12 protein-protein interaction inhibitor with oral activity, with IC50 values of 338.79 nM and 14.81 nM, respectively. WS-384 possesses anticancer activity and can cause cell cycle arrest, DNA damage, and induce apoptosis. WS-384 can be used in the research of non-small cell lung cancer (NSCLC) .
loading...
    loading...
Cat. No.: HY-123209
CAS No.: 122228-60-8
Synonyms: WS-9659 A
Target:  

Antibiotic Bacterial

Research Areas:  

Infection Cancer

Lavanducyanin (WS-9659 A) is an antibiotic targeting microbial cell membranes. Lavanducyanin is promising for research of infections and cancer adjuvants .
loading...
    loading...
Cat. No.: HY-182253
CAS No.: 2035417-32-2
Target:  

P-glycoprotein

Research Areas:  

Cancer

WS-691 is an orally active, selective ABCB1 modulator. WS-691 selectively stabilizes ABCB1 via direct binding to ABCB1. WS-691 inhibits the efflux function of ABCB1 and activates ABCB1 ATPase activity. WS-691 elevates intracellular Paclitaxel (HY-B0015) levels and reduces the required dose of Paclitaxel in cancer cells overexpressing ABCB1. WS-691 increases the sensitivity of colon cancer cells to Paclitaxel .
loading...
    loading...
  • 1